Skip to content
GenoLensGenoLens

LGI1

Chr 10q23.33

leucine rich glioma inactivated 1

Aliases:
IB1099, ETL1, EPITEMPIN
MANE:
ENST00000371418.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Early onset or syndromic epilepsy

    BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • autosomal dominant epilepsy with auditory features

    0.81
  • Seizure

    0.50
  • hereditary disease

    0.39
  • epilepsy with auditory features

    0.39
  • developmental and epileptic encephalopathy

    0.37
  • genitopatellar syndrome

    0.34
  • respiratory system disorder

    0.28
  • exostosis

    0.26
  • subarachnoid hemorrhage

    0.26
  • viral encephalitis

    0.12

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Leucine-rich glioma-inactivated protein 1

Regulates voltage-gated potassium channels assembled from KCNA1, KCNA4 and KCNAB1. It slows down channel inactivation by precluding channel closure mediated by the KCNAB1 subunit. Ligand for ADAM22 that positively regulates synaptic transmission mediated by AMPA-type glutamate receptors (By similarity). Plays a role in suppressing the production of MMP1/3 through the phosphatidylinositol 3-kinase/ERK pathway (PubMed:15047712)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.